Assessing the Nationwide Impact of a Registry-Based Randomized Clinical Trial on Cardiovascular Practice-Reference-Cited by-同舟云学术

Assessing the Nationwide Impact of a Registry-Based Randomized Clinical Trial on Cardiovascular Practice

Author:

Buccheri Sergio¹,Sarno Giovanna¹,Fröbert Ole²,Gudnason Thorarinn³⁴,Lagerqvist Bo¹,Lindholm Daniel¹,Maeng Michael⁵,Olivecrona Göran⁶,James Stefan¹

Affiliation:

1. Department of Medical Sciences, Cardiology and Uppsala Clinical Research Center, Uppsala University, Sweden (S.B., G.S., B.L., D.L., S.J.).

2. Department of Cardiology, Örebro University Hospital, Sweden (O.F.).

3. Landspitali University Hospital, Reykjavik, Iceland (T.G.).

4. Department of Cardiology and Cardiovascular Research Center, University of Iceland, Reykjavik (T.G.).

5. Department of Cardiology, Aarhus University Hospital, Denmark (M.M.).

6. Department of Cardiology, Clinical Sciences, Lund University Hospital, Sweden (G.O.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Reference28 articles.

2. Randomisation to protect against selection bias in healthcare trials.;Odgaard-Jensen J;Cochrane Database Syst Rev,2011

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

4. Vascular Aging and Clinical Trials;Early Vascular Aging (EVA);2024